Myomo (MYO) Cash from Investing Activities (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 125.05% |
| Jun 30, 2025 | 60.06% |
| Mar 31, 2025 | -40.12% |
| Dec 31, 2024 | -147.90% |
| Sep 30, 2024 | 21.22% |
| Jun 30, 2024 | 165.79% |
| Mar 31, 2024 | -254.40% |
| Dec 31, 2023 | 274.44% |
| Sep 30, 2023 | 55.62% |
| Jun 30, 2023 | -6,473.38% |
| Mar 31, 2023 | -1,231.91% |
| Dec 31, 2022 | 40.99% |
| Sep 30, 2022 | 89.13% |
| Jun 30, 2022 | 78.79% |
| Mar 31, 2022 | -939.81% |
| Dec 31, 2021 | 56.39% |
| Sep 30, 2021 | 72.98% |
| Jun 30, 2021 | -356.64% |
| Mar 31, 2021 | -187.81% |
| Dec 31, 2020 | 31.04% |
| Mar 31, 2020 | 42.62% |
| Dec 31, 2019 | -308.87% |
| Sep 30, 2019 | 88.62% |
| Jun 30, 2019 | -445.87% |
| Mar 31, 2019 | 43.10% |
| Dec 31, 2018 | 73.56% |
| Sep 30, 2018 | -117.22% |
| Jun 30, 2018 | 74.53% |
| Mar 31, 2018 | -8.64% |
| Dec 31, 2017 | -2,547.67% |
| Sep 30, 2017 | -207.07% |
| Jun 30, 2017 | 82.71% |